373 related articles for article (PubMed ID: 38542378)
1. A Current Synopsis of the Emerging Role of Extracellular Vesicles and Micro-RNAs in Pancreatic Cancer: A Forward-Looking Plan for Diagnosis and Treatment.
Trifylli EM; Kriebardis AG; Koustas E; Papadopoulos N; Fortis SP; Tzounakas VL; Anastasiadi AT; Sarantis P; Vasileiadi S; Tsagarakis A; Aloizos G; Manolakopoulos S; Deutsch M
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542378
[TBL] [Abstract][Full Text] [Related]
2. The Emerging Role of MicroRNAs and Autophagy Mechanism in Pancreatic Cancer Progression: Future Therapeutic Approaches.
Koustas E; Trifylli EM; Sarantis P; Papadopoulos N; Papanikolopoulos K; Aloizos G; Damaskos C; Garmpis N; Garmpi A; Karamouzis MV
Genes (Basel); 2022 Oct; 13(10):. PubMed ID: 36292753
[TBL] [Abstract][Full Text] [Related]
3. miR-18a and miR-106a Signatures in Plasma Small EVs Are Promising Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma.
Xu X; Bhandari K; Xu C; Morris K; Ding WQ
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108374
[TBL] [Abstract][Full Text] [Related]
4. Small RNA sequencing analysis of peptide-affinity isolated plasma extracellular vesicles distinguishes pancreatic cancer patients from non-affected individuals.
Roy JW; Wajnberg G; Ouellette A; Boucher JE; Lacroix J; Chacko S; Ghosh A; Ouellette RJ; Lewis SM
Sci Rep; 2023 Jun; 13(1):9251. PubMed ID: 37286718
[TBL] [Abstract][Full Text] [Related]
5. Thinking small to win big? A critical review on the potential application of extracellular vesicles for biomarker discovery and new therapeutic approaches in pancreatic cancer.
Vahabi M; Comandatore A; Centra C; Blandino G; Morelli L; Giovannetti E
Semin Cancer Biol; 2023 Dec; 97():50-67. PubMed ID: 37956937
[TBL] [Abstract][Full Text] [Related]
6. Exosomes in the Treatment of Pancreatic Cancer: A Moonshot to PDAC Treatment?
Papadakos SP; Dedes N; Pergaris A; Gazouli M; Theocharis S
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408980
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers for early detection of pancreatic cancer - miRNAs as a potential diagnostic and therapeutic tool?
Tarasiuk A; Mackiewicz T; Małecka-Panas E; Fichna J
Cancer Biol Ther; 2021 Jun; 22(5-6):347-356. PubMed ID: 34224317
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs: novel diagnostic and therapeutic tools for pancreatic ductal adenocarcinoma?
Mardin WA; Mees ST
Ann Surg Oncol; 2009 Nov; 16(11):3183-9. PubMed ID: 19636633
[TBL] [Abstract][Full Text] [Related]
9. Small extracellular vesicle non-coding RNAs in pancreatic cancer: molecular mechanisms and clinical implications.
Reese M; Dhayat SA
J Hematol Oncol; 2021 Sep; 14(1):141. PubMed ID: 34496946
[TBL] [Abstract][Full Text] [Related]
10. Emerging role of pancreatic stellate cell-derived extracellular vesicles in pancreatic cancer.
Sarkar R; Xu Z; Perera CJ; Apte MV
Semin Cancer Biol; 2023 Aug; 93():114-122. PubMed ID: 37225047
[TBL] [Abstract][Full Text] [Related]
11. Cancer-derived small extracellular vesicles: emerging biomarkers and therapies for pancreatic ductal adenocarcinoma diagnosis/prognosis and treatment.
Zhang W; Campbell DH; Walsh BJ; Packer NH; Liu D; Wang Y
J Nanobiotechnology; 2022 Oct; 20(1):446. PubMed ID: 36242076
[TBL] [Abstract][Full Text] [Related]
12. Plasma extracellular vesicle messenger RNA profiling identifies prognostic EV signature for non-invasive risk stratification for survival prediction of patients with pancreatic ductal adenocarcinoma.
Han Y; Drobisch P; Krüger A; William D; Grützmann K; Böthig L; Polster H; Seifert L; Seifert AM; Distler M; Pecqueux M; Riediger C; Plodeck V; Nebelung H; Weber GF; Pilarsky C; Kahlert U; Hinz U; Roth S; Hackert T; Weitz J; Wong FC; Kahlert C
J Hematol Oncol; 2023 Feb; 16(1):7. PubMed ID: 36737824
[TBL] [Abstract][Full Text] [Related]
13. Clinical Value of Circulating miRNA in Diagnosis, Prognosis, Screening and Monitoring Therapy of Pancreatic Ductal Adenocarcinoma-A Review of the Literature.
Wnuk J; Strzelczyk JK; Gisterek I
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982210
[TBL] [Abstract][Full Text] [Related]
14. Integrin α6A (ITGA6A)-type Splice Variant in Extracellular Vesicles Has a Potential as a Novel Marker of the Early Recurrence of Pancreatic Cancer.
Asada T; Nakahata S; Fauzi YR; Ichikawa T; Inoue K; Shibata N; Fujii Y; Imamura N; Hiyoshi M; Nanashima A; Morishita K
Anticancer Res; 2022 Apr; 42(4):1763-1775. PubMed ID: 35346995
[TBL] [Abstract][Full Text] [Related]
15. Circular RNA expression profiles in extracellular vesicles from the plasma of patients with pancreatic ductal adenocarcinoma.
Li Q; Geng S; Yuan H; Li Y; Zhang S; Pu L; Ge J; Niu X; Li Y; Jiang H
FEBS Open Bio; 2019 Dec; 9(12):2052-2062. PubMed ID: 31605569
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?
Brunetti O; Russo A; Scarpa A; Santini D; Reni M; Bittoni A; Azzariti A; Aprile G; Delcuratolo S; Signorile M; Gnoni A; Palermo L; Lorusso V; Cascinu S; Silvestris N
Oncotarget; 2015 Sep; 6(27):23323-41. PubMed ID: 26259238
[TBL] [Abstract][Full Text] [Related]
17. Extracellular vesicle-derived microRNAs in pancreatic juice as biomarkers for detection of pancreatic ductal adenocarcinoma.
Nesteruk K; Levink IJM; de Vries E; Visser IJ; Peppelenbosch MP; Cahen DL; Fuhler GM; Bruno MJ
Pancreatology; 2022 Jun; 22(5):626-635. PubMed ID: 35613957
[TBL] [Abstract][Full Text] [Related]
18. Cancer cell line-specific protein profiles in extracellular vesicles identified by proteomics.
Guerreiro EM; Øvstebø R; Thiede B; Costea DE; Søland TM; Kanli Galtung H
PLoS One; 2020; 15(9):e0238591. PubMed ID: 32886718
[TBL] [Abstract][Full Text] [Related]
19. Shared extracellular vesicle miRNA profiles of matched ductal pancreatic adenocarcinoma organoids and blood plasma samples show the power of organoid technology.
Zeöld A; Sándor GO; Kiss A; Soós AÁ; Tölgyes T; Bursics A; Szűcs Á; Harsányi L; Kittel Á; Gézsi A; Buzás EI; Wiener Z
Cell Mol Life Sci; 2021 Mar; 78(6):3005-3020. PubMed ID: 33237353
[TBL] [Abstract][Full Text] [Related]
20. From tumor microenvironment communicants to biomarker discovery: Selectively packaged extracellular vesicular cargoes in pancreatic cancer.
Han S; Underwood P; Hughes SJ
Cytokine Growth Factor Rev; 2020 Feb; 51():61-68. PubMed ID: 32005635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
